Download PDF

Other users also viewed these articles

All-Cause and Cardiovascular Mortality With Single Inhaler Triple Therapy Versus Double Therapies for COPD: A Systematic Review and Metanalysis Ayoub Hammadi; Clara Hoyas-Sánchez; Alejandro Romero-Linares; Lucia Álvarez-Muro; Antonio Menéndez-Lobo; Damaris Romeral-Navarro; Andrea Jiménez-Antón; Angel Almansa-López; Laura Casares-Martin-Moreno; Esther Sánchez-Álvarez; Pedro Jose Romero-Palacios; Bernardino Alcázar-Navarrete;
Arch Bronconeumol. 2025;61:594-602
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Alvar Agustí; Bartolome R. Celli; Gerard J. Criner; David Halpin; Antonio Anzueto; Peter Barnes; Jean Bourbeau; MeiLan K. Han; Fernando J. Martinez; Maria Montes de Oca; Kevin Mortimer; Alberto Papi; Ian Pavord; Nicolas Roche; Sundeep Salvi; Don D. Sin; Dave Singh; Robert Stockley; M. Victorina López Varela; Jadwiga A. Wedzicha; Claus F. Vogelmeier;
Arch Bronconeumol. 2023;59:232-48
Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit Myriam Calle Rubio; Marc Miravitlles; José Luis López-Campos; Bernardino Alcázar Navarrete; Juan José Soler Cataluña; Manuel E. Fuentes Ferrer; Juan Luis Rodríguez Hermosa;
Arch Bronconeumol. 2023;59:725-35